Tokgozoglu L and Catapano AL. The challenge of risk prediction: How good are we? Eur J Prev Cardiol 2018; 25: 418–419.
2.
Pavlović J, Greenland P, Deckers JW, et al. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study. Eur J Prev Cardiol 2018; 25: 420–431.
3.
GraversenPAbildstrømSZJespersenLet al.Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study. Eur J Prev Cardiol2016; 23: 1546–1556.
4.
BohmPScharhagJMeyerT. Data from a nationwide registry on sports-related sudden cardiac deaths in Germany. Eur J Prev Cardiol2016; 23: 649–656.
5.
GraniCChappexNFracassoTet al.Sports-related sudden cardiac death in Switzerland classified by static and dynamic components of exercise. Eur J Prev Cardiol2016; 23: 1228–1236.
6.
Finocchiaro G, Papadakis M, Dhutia H, et al. Obesity and sudden cardiac death in the young: Clinical and pathological insights from a large national registry. Eur J Prev Cardiol 2018; 25: 395–401.
7.
Gorostegi-Anduaga I, Corres P, Martinez Aguirre-Betolaza A, et al. Effects of different aerobic exercise programmes with nutritional intervention in sedentary adults with overweight/obesity and hypertension: EXERDIET-HTA study. Eur J Prev Cardiol 2018; 25: 343–353.
8.
EckelNMeidtnerKKalle-UhlmannTet al.Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur J Prev Cardiol2016; 23: 956–966.
9.
Komajda M, Kerneis M, Tavazzi L, et al. The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up. Eur J Prev Cardiol 2018; 25: 377–387.
10.
KotsevaKWoodDDe BacquerDet al.EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol2016; 23: 636–648.
11.
Kievit RF, Gohar A, Hoes AW, et al. Efficient selective screening for heart failure in elderly men and women from the community: A diagnostic individual participant data meta-analysis. Eur J Prev Cardiol 2018; 25: 437–446.
12.
Seferović PM, Krljanac G and Milinković I. Heart failure with improved ejection fraction: Is a newcomer in the family important? Eur J Prev Cardiol 2018; 25: 362–365.
13.
Jørgensen ME, Andersson C, Vasan RS, et al. Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: A systematic review and meta-analyses. Eur J Prev Cardiol 2018; 25: 366–376.
14.
SatoTYoshihisaAKannoYet al.Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction. Eur J Prev Cardiol2017; 24: 1979–1987.
15.
PiepoliMFHoesAWAgewallSet al.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
16.
Sabbag A, Mazin I, Rott D, et al. The prognostic significance of improvement in exercise capacity in heart failure patients who participate in cardiac rehabilitation programme. Eur J Prev Cardiol 2018; 25: 354–361.
17.
VigoritoCAbreuAAmbrosettiMet al.Frailty and cardiac rehabilitation: A call to action from the EAPC cardiac rehabilitation section. Eur J Prev Cardiol2017; 24: 577–590.
18.
Marmelo F, Rocha V, Gonçalves D. The impact of prehabilitation on post-surgical complications in patients undergoing non-urgent cardiovascular surgical intervention: Systematic review and meta-analysis. Eur J Prev Cardiol 2018; 25: 404–417.
